scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results
March 20, 2018 19:22 ET
|
scPharmaceuticals Inc.
Announced $147.7 Million of equity capital raising in 2017; Completed an Initial Public Offering; Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) --...
scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference
March 01, 2018 08:00 ET
|
scPharmaceuticals Inc.
BURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals Inc. to Present at the 7th Annual Leerink Partners Global Healthcare Conference
February 06, 2018 08:00 ET
|
scPharmaceuticals Inc.
BURLINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
December 12, 2017 08:00 ET
|
scPharmaceuticals Inc.
BURLINGTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals Inc. Announces Closing of Over-Allotment Option in its Initial Public Offering
November 29, 2017 09:23 ET
|
scPharmaceuticals Inc.
BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company” or “scPharmaceuticals”) (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing...
scPharmaceuticals Inc. Announces Closing of Initial Public Offering
November 29, 2017 08:00 ET
|
scPharmaceuticals Inc.
BURLINGTON, Mass., Nov. 29, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to...
scPharmaceuticals Inc. Announces Pricing of Initial Public Offering
November 16, 2017 21:05 ET
|
scPharmaceuticals Inc.
BURLINGTON, Mass., Nov. 16, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (the “Company”) a pharmaceutical company focused on developing and commercializing products that have the potential to...